ResMed Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
29 Apr 24 | Sell€85,249 | Karen Drexler | Individual | 425 | €200.58 | |
22 Feb 24 | Sell€4,609,380 | Peter Farrell | Individual | 23,535 | €219.27 | |
27 Nov 23 | Sell€418,896 | Brett Sandercock | Individual | 3,000 | €139.63 |
Insider Trading Volume
Insider Buying: RME insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 22,200 | 0.0151% |
State or Government | 129,623 | 0.0882% |
Individual Insiders | 1,284,884 | 0.875% |
General Public | 43,124,675 | 29.4% |
Institutions | 102,345,825 | 69.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,769,766 | €3.6b | 0.15% | 0.06% | |||
12,563,491 | €2.5b | 0.06% | 0.05% | |||
7,027,694 | €1.4b | 0% | 0.7% | |||
6,754,208 | €1.4b | 0.03% | 0.06% | |||
3,423,880 | €694.9m | -0.35% | 0.06% | |||
2,474,858 | €502.3m | 68.7% | 0.53% | |||
2,311,200 | €469.1m | 10,800% | 1.09% | |||
1,636,546 | €332.2m | 0% | 0.14% | |||
1,491,272 | €302.7m | 32.6% | 0.06% | |||
1,422,126 | €288.6m | -2.05% | 0.05% | |||
1,413,145 | €286.8m | -39.4% | 0.02% | |||
1,380,498 | €280.2m | 0.78% | 0.1% | |||
1,360,110 | €276.1m | 0% | 0.02% | |||
1,159,387 | €235.3m | -3.18% | 0.07% | |||
1,105,996 | €224.5m | -1.45% | 0.05% | |||
1,047,936 | €212.7m | 0% | 0.52% | |||
975,254 | €197.9m | 22.3% | 0.03% | |||
931,319 | €189.0m | 1.79% | 0.05% | |||
898,147 | €182.3m | 4.04% | 0.03% | |||
775,599 | €157.4m | -3.8% | 0.02% | |||
772,789 | €156.9m | -1.66% | 0.47% | |||
739,634 | €150.1m | 38.9% | 0.02% | |||
711,228 | €144.4m | -5.14% | 0.07% | |||
654,611 | €132.9m | -0.01% | 0.04% | |||
638,306 | €129.6m | -6.65% | 1.3% |